Luís Antón Aparicio

805 total citations
28 papers, 623 citations indexed

About

Luís Antón Aparicio is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luís Antón Aparicio has authored 28 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luís Antón Aparicio's work include Prostate Cancer Treatment and Research (5 papers), Cancer Cells and Metastasis (3 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). Luís Antón Aparicio is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Cancer Cells and Metastasis (3 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). Luís Antón Aparicio collaborates with scholars based in Spain, Mexico and Portugal. Luís Antón Aparicio's co-authors include Angélica Figueroa, M. Blanco, Rosario García Campelo, Manuel Valladares, Enrique Grande Pulido, Mar Haz‐Conde, Vanessa Abella, Luis León‐Mateos, Manuel Valladares‐Ayerbes and María del Mar Contreras and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Luís Antón Aparicio

28 papers receiving 612 citations

Peers

Luís Antón Aparicio
Shelley J. Edmunds New Zealand
Zhenhua Lin China
Joung Eun Lim South Korea
Kamilla Stach Poland
Mi Kwon Son South Korea
Ezia Bello Italy
Li-Yuan Bai Taiwan
Zishu Wang China
Anitha Shenoy India
Shelley J. Edmunds New Zealand
Luís Antón Aparicio
Citations per year, relative to Luís Antón Aparicio Luís Antón Aparicio (= 1×) peers Shelley J. Edmunds

Countries citing papers authored by Luís Antón Aparicio

Since Specialization
Citations

This map shows the geographic impact of Luís Antón Aparicio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luís Antón Aparicio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luís Antón Aparicio more than expected).

Fields of papers citing papers by Luís Antón Aparicio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luís Antón Aparicio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luís Antón Aparicio. The network helps show where Luís Antón Aparicio may publish in the future.

Co-authorship network of co-authors of Luís Antón Aparicio

This figure shows the co-authorship network connecting the top 25 collaborators of Luís Antón Aparicio. A scholar is included among the top collaborators of Luís Antón Aparicio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luís Antón Aparicio. Luís Antón Aparicio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Contreras, María del Mar, Luís Antón Aparicio, & Lourdes Arce. (2019). Usefulness of GC-IMS for rapid quantitative analysis without sample treatment: Focus on ethanol, one of the potential classification markers of olive oils. LWT. 120. 108897–108897. 28 indexed citations
2.
Cassinello, Javier, Joaquı́n Carballido, & Luís Antón Aparicio. (2016). Role of taxanes in advanced prostate cancer. Clinical & Translational Oncology. 18(10). 972–980. 16 indexed citations
3.
León‐Mateos, Luis, et al.. (2015). Enzalutamide: A new prostate cancer targeted therapy against the androgen receptor. Cancer Treatment Reviews. 41(3). 247–253. 3 indexed citations
4.
5.
León‐Mateos, Luis, Joaquín Mosquera, & Luís Antón Aparicio. (2015). Treatment of sunitinib-induced hypertension in solid tumor by nitric oxide donors. Redox Biology. 6. 421–425. 28 indexed citations
6.
Aparicio, Luís Antón, M. Blanco, Ángel Concha, et al.. (2015). Clinical implications of epithelial cell plasticity in cancer progression. Cancer Letters. 366(1). 1–10. 35 indexed citations
7.
Aparicio, Luís Antón, et al.. (2014). Role of the microtubule-targeting drug vinflunine on cell-cell adhesions in bladder epithelial tumour cells. BMC Cancer. 14(1). 507–507. 19 indexed citations
8.
Grande, Enrique & Luís Antón Aparicio. (2014). Stem Cells in Cancer: Should We Believe or Not?. DIAL (Catholic University of Leuven). 4 indexed citations
9.
Puente, Javier, Núria Laínez, María José Méndez-Vidal, et al.. (2014). Comparison of stem cell signaling pathways in long-term responders (LR) versus primary refractory (PR) patients with metastatic clear-cell renal cell carcinoma (ccRCC) under sunitinib (SU) treatment (SULONG study).. Journal of Clinical Oncology. 32(15_suppl). 4578–4578. 1 indexed citations
10.
Aparicio, Luís Antón, Vanessa Abella, Manuel Valladares, & Angélica Figueroa. (2013). Posttranscriptional regulation by RNA-binding proteins during epithelial-to-mesenchymal transition. Cellular and Molecular Life Sciences. 70(23). 4463–4477. 43 indexed citations
11.
Abella, Vanessa, Manuel Valladares, Mar Haz‐Conde, et al.. (2012). miR-203 Regulates Cell Proliferation through Its Influence on Hakai Expression. PLoS ONE. 7(12). e52568–e52568. 32 indexed citations
12.
Aparicio, Luís Antón, Manuel Valladares, M. Blanco, Guillermo Alonso, & Angélica Figueroa. (2012). Biological influence of Hakai in cancer: a 10-year review. Cancer and Metastasis Reviews. 31(1-2). 375–386. 37 indexed citations
13.
Valladares‐Ayerbes, Manuel, Mar Haz‐Conde, M. Blanco, et al.. (2011). A novel procedure for protein extraction from formalin‐fixed paraffin‐embedded tissues. PROTEOMICS. 11(12). 2555–2559. 45 indexed citations
14.
Valladares‐Ayerbes, Manuel, et al.. (2011). Hakai reduces cell-substratum adhesion and increases epithelial cell invasion. BMC Cancer. 11(1). 474–474. 25 indexed citations
15.
Pulido, Enrique Grande, et al.. (2011). Evaluation of notch and hypoxia signalling pathway in human renal cell carcinoma.. Journal of Clinical Oncology. 29(15_suppl). e21088–e21088. 1 indexed citations
16.
Díaz‐Prado, Silvia, et al.. (2010). Evaluation of COX-2, EGFR, and p53 as biomarkers of non-dysplastic oral leukoplakias. Experimental and Molecular Pathology. 89(2). 197–203. 17 indexed citations
17.
Aparicio, Luís Antón, et al.. (2009). La ciclooxigenasa-2 (COX-2) y el factor de crecimiento epidérmico (EFG) en lesiones epiteliales orales premalignas. Revista Española de Cirugía Oral y Maxilofacial. 31(3). 1 indexed citations
18.
Mellado, Begoña, Albert Font, Antonio Alcaraz, et al.. (2009). Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer. British Journal of Cancer. 101(8). 1248–1252. 39 indexed citations
19.
Díaz‐Prado, Silvia, Daniel Ayude, Rosario García Campelo, et al.. (2008). In Silico and In Vitro Analysis of Small Breast Epithelial Mucin as a Marker for Bone Marrow Micrometastasis in Breast Cancer. Advances in experimental medicine and biology. 617. 331–339. 9 indexed citations
20.
Calvo, Felipe A., et al.. (1988). Undifferentiated epithelial-rich invasive malignant thymoma: complete response to cisplatin, vinblastine, and bleomycin therapy.. Journal of Clinical Oncology. 6(3). 536–542. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shelley J. Edmunds Breakdown of academic impact, for papers by Zhenhua Lin Breakdown of academic impact, for papers by Joung Eun Lim Breakdown of academic impact, for papers by Kamilla Stach Breakdown of academic impact, for papers by Mi Kwon Son Breakdown of academic impact, for papers by Ezia Bello Breakdown of academic impact, for papers by Li-Yuan Bai Breakdown of academic impact, for papers by Zishu Wang Breakdown of academic impact, for papers by Anitha Shenoy
Rankless by CCL
2026